 The primary objective of this study is to demonstrate the effectiveness of Neutrolin as a CLS in ESRD subjects undergoing HD treatment using a permanent, cuffed, tunneled silicone or polyurethane HD catheter. The study will evaluate whether Neutrolin is superior to the active control heparin by documenting the time to CRBSI and consequently delaying the time until the occurrence of CRBSI. 